- CA$48.83m
- CA$189.33m
- CA$147.23m
- 44
- 53
- 24
- 35
Annual income statement for Anaergia, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS/A | ARS/A | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 89.7 | 111 | 127 | 162 | 147 |
Cost of Revenue | |||||
Gross Profit | 21.8 | 21.7 | 23.4 | 26.7 | 19.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 76.3 | 121 | 140 | 199 | 321 |
Operating Profit | 13.4 | -10.1 | -12.7 | -36.8 | -174 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.88 | -18.3 | -14 | -64.5 | -201 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.66 | -21.4 | -15.6 | -79 | -193 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 8.72 | -27.3 | -17.4 | -68.6 | -183 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.72 | -27.3 | -17.4 | -68.6 | -183 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.133 | -0.49 | -0.334 | -1.09 | -1.63 |
Dividends per Share |